GCIA
SCMP

Gabelli & Co Investment Advisers’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-165,900
Closed -$2.98M – 187
2017
Q4 		$2.98M Buy
+165,900
New +$2.04M 0.39% 48

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Gabelli & Co Investment Advisers's SCMP Position: Q1 2018 in Review

Gabelli & Co Investment Advisers sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 165,900 shares — an estimated $2.98M sold.

Gabelli & Co Investment Advisers first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $2.98M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Gabelli & Co Investment Advisers reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 165,900 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $2.98M.
  • Gabelli & Co Investment Advisers first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Sucampo Pharmaceuticals, Inc. position peaked at $2.98M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2018, filed 9 May 2018.